Emerald Biotherapeutics is a new biotechnology group that has acquired technologies from several biotechnology companies. Their current pipeline focuses on rare neurodegenerative conditions and solid tumors desperately in need of new and improved therapeutics. One of their leading programs focuses on developing a technology out of University of New Mexico to treat ovarian cancer. Further, Emerald has partnerships with Rutgers, The State University of New Jersey, Washington University in St. Louis, and the Veteran’s Administration.
See also, “ Startup Advanced Concepts in Biology Exploring New Ways to Fight Cancer with Technology Developed at the University of New Mexico,” on the UNM Rainforest Innovations website here: https://innovations.unm.edu/startup-advanced-concepts-in-biology-exploring-new-ways-to-fight-cancer-with-technology-developed-at-the-university-of-new-mexico/
